Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda
- 26 March 2010
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 22 (3), 271-278
- https://doi.org/10.1080/09540120903193625
Abstract
Gender differences in treatment outcomes of 305 persons living with HIV receiving antiretroviral treatment (ART) in Kabarole district, western Uganda, were evaluated. The primary treatment outcome was virological suppression defined as HIV-1 RNA viral load (VL) 400 copies/ml) as compared to males (odds ratio 2.14, 95% confidence interval 0.99–4.63, p=0.05). While females had a significantly higher baseline CD4 cell count at initiation of treatment compared to males, the increase in CD4 cell count after six months on ART was similar in males and females. The reasons for better ART outcomes for females should be further investigated. Ideally, ART programs should work toward equitable treatment outcomes for men and women, if the cause of the gender differential lies in patient behavior and the way ART services are delivered.Keywords
This publication has 33 references indexed in Scilit:
- Gender differences in health status and care among HIV-infected minority drug usersAIDS Care, 2008
- Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South AfricaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Association of Race and Gender with Use of Antiretroviral Therapy Among HIV-infected Individuals in the Southeastern United StatesSouthern Medical Journal, 2007
- Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic reviewJournal of Antimicrobial Chemotherapy, 2007
- Gender Differences in Survival in an HIV/AIDS Cohort from São Paulo, BrazilAIDS Patient Care and STDs, 2007
- Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic reviewBMC Public Health, 2007
- Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugsHIV Medicine, 2007
- Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected personsJournal of Medical Virology, 2006
- Longitudinal Trends in Antiretroviral Use in a Cohort of Men and Women in Ontario, CanadaAIDS Patient Care and STDs, 2006
- HIV treatment in drug abusers: impact of alcohol useAddiction Biology, 2003